Offshore Telemedicine Prescription Fraud: Real Pharmacies, Visits That Never Happened

Private insurers paid more than $758 million in an offshore telemedicine prescription fraud scheme, according to criminal court filings and proceedings described by the Justice Department. The network connected U.S. pharmacies, doctors’ identities and Moscow billing teams to generate prescriptions without real medical visits. Patients were offered free medication, and physicians were misled about the consultations behind prescriptions. Someone working at a pharmacy could see the payments arrive without seeing how the prescriptions had been created.

The operation ran from 2017 through 2022. Call centers initially operated in Utah and later in Russia, while the pharmacies supplied an American address and an existing relationship with an insurer.

How the Prescription Became the Product

The network used the appearance of a medical consultation to generate prescriptions that pharmacies could bill. According to the Justice Department’s account of court filings and proceedings, call-center employees contacted people with private health insurance and offered medication at no cost, without medical examinations to establish whether they needed it.

A refusal did not stop the process. The network generated prescriptions whether or not the person agreed to receive the medication.

The doctors heard a different story. They were recruited to review prescriptions from nurse practitioners and physician assistants after telemedicine visits. In most cases, those visits had never happened. The network generated prescriptions under the recruited physicians’ names and National Provider Identifier numbers, and many beneficiaries never received the drugs.

The court’s amended memorandum and order in the pharmacy operator’s criminal case adds that prescriptions were often generated without the physicians’ authorization. For a doctor who recognizes an order carrying their identifier, the important connection is between what they actually reviewed and what the pharmacy submitted for payment.

The commercial purpose becomes clear at the pharmacy. A purported consultation produced the prescription needed for a reimbursement request. The promise to the patient was free medication. Private insurers paid for prescriptions generated even when patients refused the drugs, under doctors’ names used without their authorization.

From U.S. Pharmacies to Moscow Billers

The pharmacies mattered because they already had the relationships needed to submit insurance claims. The pharmacy operator’s criminal-case memorandum describes the acquisition of existing brick-and-mortar pharmacies with pharmacy board registrations and private-insurer relationships. Buyers who appeared to own the businesses concealed the people actually controlling them.

That concealment had a business purpose. The court described an effort to delay insurers’ discovery of the fraud and keep reimbursements flowing until the insurers stopped paying. A pharmacy could retain its familiar place in an insurer’s network while its ownership, systems and operating instructions served a different business.

The Justice Department’s account of the criminal court filings and proceedings places these pharmacies in Brooklyn, Staten Island, Manhattan and Long Island, as well as New Jersey, Pennsylvania, Texas, Michigan and Alabama. The court’s memorandum and order in the billing manager’s criminal case describes billers entering data through remote billing software and sending electronic reimbursement requests from Moscow for prescriptions the American pharmacies had purportedly filled.

The Justice Department’s account of the criminal court filings also describes a participant who oversaw custom software development and forwarded fraudulent prescriptions to licensed physicians for approval. Another participant oversaw the call centers in Utah, Russia and elsewhere overseas. The software and call-center roles connected patient solicitation to the doctors recruited to review prescriptions.

The People Who Kept the Network Running

The criminal documents describe distinct responsibilities for billing, pharmacy operations and the movement of money. Each role controlled a different part of the same operation.

The Billing Manager Chose What Paid

The court’s criminal-case memorandum identifies Warner West Pharmacy and Dharman Pharmacy as subsidiaries of Sutton Pharmacy and says the billing manager worked at both. It describes him training and supervising the people entering data and submitting fraudulent reimbursement requests. Working under the network leader’s direction and with another participant, he identified insurers with the highest paid reimbursements and generated requests for medications with the highest reimbursement amounts.

He also installed, or arranged the installation of, the pharmacies’ computers and remote billing software. After his billing team relocated to Moscow, he traveled there to supervise it.

The Pharmacy Operator Managed the Local Business

The court’s amended memorandum and order in the criminal case identifies the pharmacy operator as president and manager of Open a Pharmacy, LLC, a business involved in the scheme. It describes him as involved in purchasing and managing at least 30 pharmacies.

He visited pharmacies, hired and trained employees, supervised or fired staff, dealt with landlords and collected reimbursement checks sent through the mail. He forwarded bills and payroll information to the participant handling payments. He also told his co-conspirators about insurer audits and terminations and closed pharmacies.

The staffing, check collection, audit response and closure decisions show who was running the pharmacies behind the ownership paperwork. An employee dealing with that operator could know more about actual control than the name on the business suggested.

The Money Mover Connected Owners and Accounts

The criminal court filings and proceedings described by the Justice Department identify another participant coordinating the laundering of fraud proceeds through straw owners and shell entities for the pharmacies. He personally wired millions of dollars internationally.

The department also described proceeds moving from overseas through shell companies to buy pharmacies and conceal the participants’ involvement. Money movement therefore helped acquire the businesses used to generate further claims, as well as hide the people behind them.

Aliases and encrypted communications were part of the concealment. For someone familiar with the payments, the useful connection is between the person giving instructions, the company receiving the transfer and the pharmacy whose bills were being paid.

Pharmacy Claims Built on Visits That Never Happened

The Justice Department’s account of the criminal court filings reports more than $1.97 billion in fraudulent submissions, based on third-party billing records. The billing manager’s criminal-case memorandum explains the defect behind those claims: there were no valid telemedicine visits and no properly diagnosed medical need for the prescriptions.

The pharmacy operator’s criminal-case memorandum gives a closer view of the businesses he helped run. For just seventeen of the pharmacies associated with him, third-party billing records showed more than $843 million claimed and more than $195 million paid.

A Similar Prescription Business Hid the Referral Source

HealthRight supplies a useful parallel: the remote prescribing operation and the pharmacy reimbursement business can tell different stories about the same prescription. In a court opinion describing the criminal trial involving Synergy Pharmacy, the court examined HealthRight’s role in generating prescriptions with little clinical involvement, concealment of that referral source, and representations made to pharmacy benefit managers.

The court rejected the argument that delivering actual drugs to actual patients answered the fraud case. The deception concerned how insurers’ money was obtained. That comparison makes the payment relationship central: what the pharmacy represented about a prescription can matter alongside whether a package reached the patient.

What Evidence Is Needed to Prove Fraud?

For this network, the useful evidence connects patient contact, prescription generation, pharmacy control, billing instructions and insurer payments. We examine those connections with an insider who knows what happened at one or more of those points.

Telehealth businesses can separate clinical care from staffing, scheduling, technology, billing and collections. In this case, the pharmacy operator’s criminal memorandum shows how instructions about payroll, reimbursement checks and insurer audits can reveal who controlled the business behind its ownership paperwork.

If your information concerns government-paid claims, our whistleblower experts can assess the False Claims Act side with you. A whistleblower case under the False Claims Act can pay 15% to 30% of what the government recovers.

You Know Who Gave the Instructions

If you saw prescriptions appear without consultations, remote billers take over pharmacy claims or payments move through owners who were only names on paper, talk with our whistleblower experts. We build your strongest case around the orders, control and money, bring in healthcare fraud whistleblower lawyers who understand pharmacy reimbursement networks, and stay beside you throughout the case.